• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    A novel Antibiotic C-15003 P-3 is specifically produced by cultivating a microorganism of the genus Nocardia in a culture medium containing valine or isobutyric acid and/or their derivatives. The Antibiotic C-15003 P-3 is useful as an antifungal, antiprotozoan and antitumor agent.
    公开号:SU1036251A3
    申请号:SU782688152
    申请日:1978-11-17
    公开日:1983-08-15
    发明作者:Хигасиде Еидзи；Хатано Казунори；Асаи Мицуко
    申请人:Такеда Кемикал Индастриз,Лтд (Фирма)；
    IPC主号:
    专利说明:

    oo yes to
    01 The invention relates to microbiology and concerns npj, ani antibiotics.  The proposed antibiotic is new and the method for its preparation is not described in the patent and scientific literature.   The aim of the invention is the preparation of an antibiotic of the general formula wherein R is -CO-OH-CH; -CO-OH IJ.  -CO-GHjCHj-CHj, or -CO-CH ,.  iCHj This goal is achieved by the fact that the strain Nocardia sp.  I C-15003 (ATCC-31281, IFO 13726) is grown in a nutrient medium containing sources, carbohydrate, valine or isobutyric acid additives or their derivatives, followed by isolation of the desired product.  In addition, a mixture of valine and isobutyric acid is used as an additive.  Strain Nocardia sp.   C -15003 antibiotic producer - isolated from the soil and deposited at the Research Institute of Fermentation Agercyof Industrial Science and Techno logy (FERM) under number 3992, at the Institute of Fermentation, Osaka (IFO) under serial number 13726 and in the American collection of crop varieties ( ATSS), Maryland USA under the number ATSS-31281.  Morphological signs.  Vegetative mycelium grows well on agar, faK and in liquid medium.  Hyphae reach from 0.8 to 1.2 µm in diameter; in some cases, they can be divided into fragments resembling bacillus sticks or short branched hyphae. A piece that grows well on various media, the image of a body similar to monoliths (50-200x200x1000 µm) on which further growth of the airborne target occurs.  Aerial mycelium is a wave-like straight or loop-shaped helix, In the second case, conidia are formed.  Cell suspensions obtained from the surface of the cultures contain many elongated ellipsoidal (0.08 1 / 2x4.8-6.8 MKMj and ellipsoidal spans (0.8-1.2x1.0-2.0 μm) Taurus-like .  The strain of horish grows at times / primary media, and the vegetative mycelium can range from colorless to pale yellow in the initial Phases and from light yellowish reddish brown to yellowish reddish brown in the late phases.  The strain produces soluble pigments in various environments.  Aerial mycelium has a powdery appearance and possesses reduced growth, its color varies from white to yellow or from light yellow to tan.  Saccharose nitrate agar.  Growth moderate, vegetative mycelium (bright yellow melon to amber reddish-brown) forms a body similar to a monolith.  Aerial mycelium scanty, white.  Soluble pigment is absent or pale yellowish-tan.  Glycerolino-nitrateguard agar.  Growth is moderate.  The vegetative mycelium is light ivory and forms bodies that look like monoliths.  Aerial mycelium is moderate, white.  Soluble pigment is missing.  Glucose-aspartic agar.  Growth moderate, vegetative mycelium from bright color of calendula to bright yellow.  Aerial mycelium scanty, white.  Soluble pigment yellow.   Glycerin-aspartic agar.  Growth is moderate.  Vegetative mycelium of light ivory color forms a body like a monolith.  Aerial mycelium scanty, white.  Soluble pigment is missing.  Agar on starch.  Growth is moderate.  From light ivory to light wheat, forms bodies that look like monoliths.  Aerial mycelium plentiful, light ivory.  Soluble pigment is missing.  Agar on oat flour.  Growth is moderate, from light ivory to colonial yellow, forms bodies that look like monoliths.  Aerial mycelium scanty, from white to light yellow.  Soluble pigment is missing.  Gyrosin Agar.  Growth is moderate, from light ivory to light yellow melon, forms bodies that look like monoliths.  Aerial mycelium is moderate, from white to light ivory.  Soluble pigment col. eta camel.  Physiological signs.  Temperature; growth interval 12.  The temperature range in which there is a good growth of the BOB of stuffy micelles is 20-35s.  It is diluted with gelatin, hydrolyzes starch, restores nitrates, peptonizes milk, but does not coagulate, and casein decomposes.  Naagare with peptone and yeast extract does not produce pigment melanoid pigments, forms on tyrosine agar.   Tyrosine decomposes, xanthini hypo | xanthine does not decompose, tolerance to lysozyme is positive, tolerance to. sodium chloride 2%, very well absorbs fructose, mannose, grows well on glucose, sucrose, mannitol, soluble starch. ;.  Absorbs xylose, arabinose; trehalose, melibiosis, rhamnose, galactose.  Poorly absorbs raffinose, maltose, i-inositol, D-sorbytol, lactose, and glycerin do not digest.  . . .   A microorganism of the genus Noca rdta can both.  in general, all organisms, to undergo variations and mutations that occur either spontaneously,.  or caused by artificial means.  For example,.  Multiple variants are possible, which can be obtained by irradiation with x-rays, / gamma rays, ultraviolet radiation, and t. d. , by isolating a single cell, by cultivating a culture on media containing different chemicals, or as a result of any other mutagenic treatment, the same as mutants formed from the strain should not be considered.  as representatives of any other kind.  Any of these variants or mutants capable of abating C-15003 P-3, P-3 and / or P-4 can be used for the purposes of the invention. .  For example, strain C-15003 can be subjected to various mu. There are other treatments and mutants that practically do not have the ability to produce soluble pigments: mutants with a colorless substrate mycelium, with a yellowish-green, reddish-reddish-brown or orange-red mycelium; mutants / hyphae of which are ready for fragmentation into bacillary elements or into fragments of short branched hyphae j and.  mutants with abundant belm aerial mycelium or practically without aerial mycelium.  f Valine and / or isobutyric acid as derivatives can be used as other substances.  Examples of derivatives are esters such as C, -C alkyl. esters (for example, methyl ester, -ethyl ester) of these compounds, amides, such as amide or alkylamide {for example, H-methylamide: P-ethylamide) These compounds, their keto acids (for example, 6t-ketoisovaleric acid), salts of these compounds such as hydrochloride, sodium salt, potassium or calcium salt, Valine can be used as.  D-forms, L-forms or DL-forms.  Said additive substances may be mixtures of valine, isobutyric acid and / or their "derivatives.  i These substances are usually added to the medium in an amount of from 0.01 to 1.0% (weight. . . / volume), and preferably from about 0.1 to about O, 5% (weight. / volume) at any time of cultivation as the cultivation of the species Nocardia C-15003 proceeds, preferably at the initial cultivation.  The culture medium can be either liquid or solid and may contain carbon and az sources. ota, which the strain assimilates and digests, inorganic substances, nutrients, as carbon sources use glucose, lactose, sucrose, maltose, dextrin, starch, glycerin, mannitol, sorbitol, fats and oils (for example, oil from soybeans, pigs) e.  fat, chicken fat).  As a source of nitrogen, meat extract, yeast extract, dry yeast, soy flour, liquid from soaking grains, peptone, flour 5 are used; cotton seeds, myoc 5u, urea, ammonium salts (for example, ammonium sulfate, ammonium chloride, ammonium nitrate), nitric acid salts (sodium nitrate, potassium nitrate).  In addition, the medium may contain salts of sodium, potassium, calcium, magnesium, iron, manganese, zinc, cobalt, nickel, salts of phosphoric and boric acids.  The medium may also contain as additives various vitamins (for example, B, B, nicotinic acid, s), nucleic acids -.  (for example, purine, pyrimidine and their derivatives).  To establish the pH, inorganic acids and / or alkaline metal or, appropriate bases as pH-adjusting agents, are added to the medium, as well as. also oils, fats, surfactants and antifoaming agents.  The cultivation is carried out in any stationary conditions for growing crops with shaking / aerobic immersion and others.  Aerobic immersion is preferred. .  Incubation is carried out at 20-35 ° C at an initial pH of | 5.5-8.5.  The preferred range is from 23 to at pH 6.5-7.5.  Cultivation time 48-240 h.  Strain C-15003 is inoculated into a culture strain 1, which includes  %; soluble starch 3; ammonium chloride 0,2; magnesium sulfate 0.05; monopotassium phosphate 1.09} dipotassium phosphate 2.09 ferrous sulfate 0.001 and additional substances; or in the culture medium 5, which includes,%: dextrin 5; grain soaking liquid 3; peptrn 0.1; calcium carbonate 0.5 and additional substances.  Then the inoculated medium is cultivated at 200 rpm at 28 ° C for 144 hours on a rotator shaker or fermenter.   The results obtained for the 1G and N media are given in Table.  one.  Antibiotic activity is determined using a paper disk to quantify on Talaromyces-avellaneus IFO 7721 as an experimental organism.  Since the antibiotic obtained in the fermentation broth is a refined neutral substance, it is isolated from the broth.  Antibiotic P-3 is extracted from a nutrient filter and water-immiscible organic solvents such as fatty acid esters, for example ethyl acetate and amyl acetate), alcohols (e.g. butanol), halogenated hydrocarbons (e.g. dichloromethane, chloroform), and ketones (for example methyl isobutyl ketone).  This antibiotic P-3 from the filtrate is carried out at a pH close to neutral, and is preferably extracted with ethyl acetate at pH 7. The extract is washed with water and concentrated under reduced pressure.  A non-polar solvent, such as petroleum ether or hexane, is then added to the concentrate and the crude product containing the active compound as a precipitate is recovered.  The RAW product, if desired, is sequentially subjected to different cleaning methods.  Adsorption chromatography can be used; silica gel, alumina, macroporous nonionic resins are used as adsorbents.  P-3 from the crude product is isolated on a silica gel chromatography using petroleum ether and hexane and eluted by adding a polar solvent (such as ethyl acetate, sshcheton, ethanol or methanol), or a goledinated hydrocarbon (such as dichloromethane or chloroform containing rn solvent, such as alcohol (for example, methanol or ethanol), ketone (for example, acetone or methyl ethyl ketone), bleached macroporous antibiotic as a means of purification; resin - adsorbate, then the elimination of antibiotic P-3 is carried out with a mixture of water and lower alcohol om, lower kegon or complex ether.  AT.  methanol, ethanol, propanol, or butano is used as the lower alcohol, and acetone or methyl ethyl ketone is used as the lower ketone.  The crude product is dissolved in a 60% methanol-water mixture and adsorbed on a DIP-10 column. The column is washed with a 70% methanol / water mixture and then eluted with a 90% methanol-water mixture.  The fractions containing antibiotic P-3 are collected and concentrated under reduced pressure.  5-8 volumes of ethyl acetate are added to the dry product and the mixture is allowed to stand, after which crystals of antibiotic P-3 are isolated, the yield is 90%.  Physical and chemical properties of P-3 are given below.  Antibiotic C-15003 R-3.  Cjjh jCJNiOg 635,169.  Melting point 190-192С, Specific rotation (ct) |, 2 -136 ± 10 (С 0.375 СНС: 4зЬ Found,%: С 60.06; H 7.04; N 4.33; CI 5.37.  Calculated,%: C 60.51; H 6.82; N 4.41; CI 5.58.  Ultraviolet absorption spectrum in methanol, nm (): 233 (30250); 240 (pl.  284S5; 252 (27640); 280 (5750); 288 (5700}, Infrared Absorption Spectrum, CM-, KBr: 1740; 1730; 1670; 1580; 1445; 1385; 1340; 1255; 1180; 1150; 1100; 1080; 1038.  NMR spectrum 100 MHz c. / million: 1.27 / d / (ZN); 1.28 / d / (3N).   Mass spectrum, t / e: 573; 485; 470; 450.  Insoluble in petroleum ether, hexane and water. - Partially soluble in benzene and ether.  Soluble in chloroform, ethyl acetate, acetone, ethanol, methanol, pyridine, tetrahydrofuran and dimethyl sulfoxide.  Color reaction: Dragendorf is positive; Belstein - positive.  Biological activity.  Antibacterial activity.  By the method of paper discs, inhibitory concentrations of a strain grown on trypticase soybean agar (BBL) against microorganisms are listed below.  Thus, filter paper discs (Touo Seisakusho, thin type, 8 mm in diameter), each saturated with 0.02 ml of a solution of 300 µg / ml P-3 concentration, are placed on plates inoculated with microorganisms / listed below, respectively, to determine the minimum inhibitory concentration , P-3 has no activity against the following microorganisms: Escherichia coli, Proteus vulgaris, Proteus miratoilis, Pseudomonas aerugiaosa, Staphylococcus aureus, Bacullus subtilis.  Bacillus cereus, Klebsiel la pneumonia e, Serratia marcescens and Mycobacterium avium. On the other hand, the growth of Talaromyces avellaneus fungi is inhibited by P-3 on an agar plate containing 3.5 g of disodium phosphate, 0.5 monopotassium phosphate, 5 g of acidic phosphate, yeast extract ( Difco), 10 g glucose, 15 g agar, 1000 ml distilled water, rF 7.0.  Minimum inhibitor concentration 3,0 µg / ml for P-3.  Then, mTaiviM Tetrahymena pyriformis W is cultivated as a test organism on a test medium consisting of 20 g of proteco peptone (Difco), 1 g of yeast extract, 2 g of glucose, 1000 ml of distilled water and 10 MP 1m of phosphate buffer, pH 7.0 , at a temperature of 4448 hours, and the activity of inhibiting growth of P-3 against the simplest ones was determined by the method of serial dilutions.  Growth inhibition was found to be observed at a concentration of 1 µg / ml.  P-3 has activity against the following microorganisms: Fusicladium Ievieri, Helminthosporium sigmoidium yar.  i r regjj 1 a re, Pyricularia oryzae, Cochlioborus raiyabeanus, Scherotinia sc rerot i Pellicularia orum Sasakii, Trichophyton. rubrum, Rhadotorula rubra and Cryptoco. ccus. neoformans.  Antitumor activity.  The therapeutic effect of P-3, administered intraperitoneally for 9 days, against leukemia P388 in mice (1x10 cells) for living, was studied.  transplanted intraperitoneally.  The results obtained showed that in units of the degree of prolongation of life span, these compounds possess antitumor activity of pores D1 and 200% at a dose level of 0.00625 Mk / kg / day.  Toxicity.  In acute toxicity tests carried out in mice, which involved intraperitoneal injections of P-3, all the antibiotics tested yielded an LD value. j 0.625 mg / kg and LDf, 0.313 mg / kg; Example 1  40 MP of seed culture medium containing,% s glucose 1.0; bactotrypton 2.0; bacto-yeast extract 1.2, pH 7.0, poured into a 200-ml Erlenmeyer flask.  After sterilization, inoculate Nocardia SP No. C-15003 on Wednesday (IFO 13726, ATCC 31281, FERM P 3992).  The inoculum is incubated with a rotating shaker (200 rpm) to obtain a seed-culture.  Thrilled culture thrice. rinse with sterilized distilled water and the washed cells are extracted to the initial amount of sterilized distilled water.  One part by volume of the obtained substance is inoculated into the main one at 40 h.  by volume of the main nutrient medium containing,%: soluble starch 3; ammonium chloride 0,2} magnesium sulfate 0.05; monopotassium phosphate 1.09; dipotassium phosphate 2.9; ferric sulfate 0.001 and L-valine 0.1, and basic nutrient medium are cultured 28 s for 8 days in a rotating shaker (200 rpm).  The total amount of C-15003 obtained is 16 µg / ml, 95% (w / w. %) of it was P-3.  Example 2  Ready to sow.  cultures as in the example. 1,500 ml of a seed culture is inoculated into a 2000 ml Sakagushi flask and. cultivated at. 3 for 48 h in a rotating shaker (100 rpm) to obtain an inoculum nta.  The inoculum is placed in 100x103 h by volume of medium containing,%: Glucose 2.0; soluble starch 3.0; liquid from the soaked grain 1.0; Soya flour 1.0; polypepton 0.5; sodium chloride 0.3; calcium carbonate 0.5; pH 7.0, at 200x10; h by volume stainless steel fermenter. The cultivation is carried out for 48 h at a rate of aeration of 100x103 h in volume / min and opening 200 rev / min.  Nutritious Oulon (10x10 about. h ) transferred 100x10 hours by volume of basic nutrient medium containing,% g dextrin 5; grain soaking liquid 3 | peptone 0.1 L-valine 0.5; Calcium carbonate 0.5, pH 7.0, in a 200x1O3 by volume fermentor, made of stainless steel, and cultured for 4 days at 28 s with aeration 100x10 h in volume / min and a stirring speed of 150 rpm  The total amount of C-15003 obtained is 12 mg / ml, and P-3 in C-15003 is about 98% (weight. /weight. %).  PRI me R. 3  50 liters of acetone are added to 95 liters of the liquid nutrient medium obtained in Example 2. The resulting mixture is warped for 30 minutes, Hyflo-supercell is added 2x10 hours, mixed well, then filtered on a filter under pressure, resulting in 135 filtrate.  50 ml of sona and 90 liters of ethyl acetate are added to the filtrate, and the mixture is stirred and extracted.  The procedure described is repeated.  The resulting ethyl acetate jelly is combined and washed twice with 80-liter portions of water.  1x10 hours is added to the layer.  anhydrous sodium sulfate, dried and concentrated to 200 MP.  Petroleum ether is added to the preparation of cobalt, and the o precipitate that has developed is isolated by filtration, resulting in 35 g of crude product.  50 m of ethyl acetate is added to the crude product and the mixture is stirred.  The insoluble part was isolated by filtration, and added to the filtrate. 10 g of silica gel.   stirring the resulting mixture.  tat is distilled off under reduced pressure. nii.  The residue is placed in the top hour of the column. with silica gel {500, mp), the elution is carried out successively 500 MP n-hexane} 500.  ml of a mixture of n-gyo san-ethyl acetate (3: l) f2000 ml of a mixture of n-hexane-ethyl acetate (1: 1) and 2000 ml of a saturated aqueous solution of ethyl acetate.  When this eluate collected in.  5 o milliliter fractions.  One milliliter from each fraction is concentrated to dryness and 0.1 ml of ethyl acetate is added to the concentrate to make a mixture.  The mixture gives a spot at a distance of 2.5% from the bottom edge of the silica gel-glass plate and appears about 17 cm with ethyl acetate saturated with water.   manifestations are carried out. determination by ultraviolet (2537 A).  Active fractions Rf 0.42 are collected and concentrated under reduced pressure to 2 ml.  To this concentrate, 20 ml of petroleum ether are added, resulting in 9.1 hours.  raw crystals.  After dissolving the crude crystals in 20 m of warm ethyl acetate and cooling off 0.85 hours.  R-3 crystals.  Melting point 189-190 ° C (p-3: 97% (wt. /weight).  PRI me 4.  In 400 ml of 50% - "Hoi1 Solution-methanol, 20 g of the crude product obtained by Example 3 is dissolved.  A column of 2.5 cm in diameter is filled with 1000 mlda of -HP-U with 3000 ml of a 50% methanol-water mixture. The sample sample prepared in such a way is passed through a column and washed using 1000 ml of 60% methanol and continuously . eruptive gradient elution with 7500 ml of a 60% methanol mixture — in the water and 7500 ml with a 95% methanol-water mixture.  The slurry is collected in 75 milliliter fractions and each fraction is examined by thin layer chromatography on; or the gel described in Example 3: Fractions 145-153 are collected and concentrated.  508 MP iodine and 1000 ml of ethyl acetate are added to the concentrate.  The solution is then shaken in a separatory funnel and the aqueous layer is separated after washing twice with 300 ml of water. , silt acetate layer. dried. over anhydrous sodium sulfate, concentrated and allowed to settle.  The resulting crystals R-3 is filtered and dried. - OUTPUT P-3 880 mg.   .  Melting point 188-190 ° C (P-3; 95% (w / w)). .  Example 5  Irpolya instead of b-valine in example 1, valine methyl ester; Valine N-methyl ester; valine hydrochloride;: L-ketoisovaleric acid; methyl ester isomal acid. isloty; N-methyl ester of isobutyric acid or a mixture of vignone and isobutyric acid. , get antibiotic P-; 3.  Antibiotic P-3 has a high inhibitory activity against fungal and protozoa organisms and can be used as a fungicidal agent, and can also be used as an antitumor drug.  As a fungicide, it can be used to assess bacterial ecology in soil, activated sludge, animal fluids, etc. d.  So, if you need to isolate valuable bacteria from soil samples or to evaluate the effect of bacteria, regardless of fungal or protozoa organisms. In order to work and study the active sludge systems used for wastewater treatment, an antibiotic can be used to obtain the selective growth of bacterial flora, which is accompanied by growth suppression of fungal contamination.  or protozoa, organisms in the sample.  Usually, the sample is added to a liquid or solid medium and, on a 1 MP medium, 0.1 ml of a solution containing 10-100 µg / ml of the antibiotic in a 1% methanol / water mixture is added, after which the sample is incubated.  P-3 can also be used as a bactericidal agent for controlling plant diseases caused by the microorganisms mentioned above.     Usually p-3 is used in the form of a 1% methanal aqueous solution containing 0.5–5 μg / ml of antibiotic.  For example, P-3 can be used to control reddish-brown leaf rot blast, splenitis. blotch of istria and leaf diseases of plants.  The proposed method allows to obtain a new antibiotic.  but In the Add Time column, the additive substance added the medium as one of the ingredients.
    权利要求:
    Claims (2)
    [1]
    1. METHOD FOR PRODUCING ANTIBIOTIC S-15003 P-3, characterized in that the strain Nocardia sp.
    No. C-15003 (ATCC-31281, IF0 13726) is grown in a nutrient medium containing sources of nitrogen, carbon, additives of valine or isobutyric acid or their derivatives, followed by isolation of the target product.
    [2]
    2. The method according to claim 1, characterized in that a mixture of valine and isobutyric acid is used as an additive.
    microbio
    类似技术:
    公开号 | 公开日 | 专利标题
    SU1036251A3|1983-08-15|Process for preparing antibiotic c=15003 p-3
    US4162323A|1979-07-24|Antibiotic N-acetyl-dehydro-thienamycin
    EP0031430B1|1983-12-28|A method for the production of antibiotic c-15003 p-3
    PETERSEN et al.1994|Production of cladospirone bisepoxide, a new fungal metabolite
    EP0048585A1|1982-03-31|Antibiotics TM-531 B and TM-531 C
    US5021406A|1991-06-04|2-pyranone derivative and process for production thereof
    SU882414A3|1981-11-15|Method of preparing c-15003 p-4 antibiotic
    DK146342B|1983-09-12|METHOD FOR PREPARING ANTHRACYCLING LYCOSID ANTIBIOTICS DESIGNED MA 144-M1 AND MA 144-M2 OR NOT TOXIC ACID ADDITION SALTS OR COMPLEXES THEREOF WITH DESOXYRIBONUCLEIC ACID
    US5320955A|1994-06-14|10'desmethoxystreptonigrin production by Streptomyces albus
    EP0329361B1|1995-12-06|2-pyranone derivatives and process for production thereof
    US3909361A|1975-09-30|Novel antifungal antibiotic substance, process for production of the same, and agricultural and horticultural fungicidal composition containing said substance
    DE2746209C2|1990-10-31|
    DE3003359C2|1987-10-01|
    EP0042172B1|1984-11-07|Antibiotic compounds, pharmaceutical compositions containing such compounds, process for production thereof
    US4565781A|1986-01-21|Antibiotic, Spicamycin
    US5536850A|1996-07-16|Substance DC114-A1
    US3711605A|1973-01-16|Antibiotic a150a
    US3956487A|1976-05-11|Novel antifungal antibiotic substance, and agricultural and horticultural fungicidal composition containing said substance
    KR820001204B1|1982-07-01|Method for producing antibiotic c-15003 p-3
    EP0259778B1|1990-03-28|Antibiotically effective gentisine acid derivative
    CH637137A5|1983-07-15|Antibiotic and process for its preparation
    US4216206A|1980-08-05|Antibiotics S 53210/A-I, S 53210/A-II and S 53210/A-III
    US4220718A|1980-09-02|Antibiotics produced by Cytospora sp. W.F.P.L. 13A
    JPH0613499B2|1994-02-23|Patchoulide and its manufacturing method
    US3956276A|1976-05-11|Novel antifugal antibiotic substance, process for production of the same, and agricultural and horticultural fungicidal composition containing said substance
    同族专利:
    公开号 | 公开日
    CH640270A5|1983-12-30|
    ES475178A1|1979-05-16|
    IT7829922D0|1978-11-17|
    IT1206651B|1989-04-27|
    GB2011385A|1979-07-11|
    GB2011385B|1982-05-26|
    JPS5473194A|1979-06-12|
    US4228239A|1980-10-14|
    DK144657C|1982-11-22|
    DK514378A|1979-05-19|
    PL122463B1|1982-07-31|
    DK144657B|1982-05-03|
    PL211028A1|1979-07-16|
    HU179600B|1982-11-29|
    NL7811325A|1979-05-22|
    FR2409307B1|1981-03-06|
    FR2409307A1|1979-06-15|
    DE2849696A1|1979-05-23|
    JPS6016236B2|1985-04-24|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US3902968A|1974-04-25|1975-09-02|Merck & Co Inc|Fermentation process|
    JPS58876B2|1975-11-19|1983-01-08|Fujisawa Pharmaceutical Co|
    JPS6010718B2|1977-03-31|1985-03-19|Takeda Chemical Industries Ltd|
    FR2385714B1|1977-03-31|1982-05-14|Takeda Chemical Industries Ltd|
    US4162940A|1977-03-31|1979-07-31|Takeda Chemical Industries, Ltd.|Method for producing Antibiotic C-15003 by culturing nocardia|
    US4151042A|1977-03-31|1979-04-24|Takeda Chemical Industries, Ltd.|Method for producing maytansinol and its derivatives|US4162940A|1977-03-31|1979-07-31|Takeda Chemical Industries, Ltd.|Method for producing Antibiotic C-15003 by culturing nocardia|
    JPS55162791A|1979-06-05|1980-12-18|Takeda Chem Ind Ltd|Antibiotic c-15003pnd and its preparation|
    JPS6253158B2|1979-09-19|1987-11-09|Takeda Chemical Industries Ltd|
    JPS6316120B2|1979-12-28|1988-04-07|Takeda Chemical Industries Ltd|
    US6573074B2|2000-04-12|2003-06-03|Smithkline Beecham Plc|Methods for ansamitocin production|
    US20110313230A1|2001-05-11|2011-12-22|Terrance Grant Johns|Specific binding proteins and uses thereof|
    US6790954B2|2002-01-29|2004-09-14|Immunogen, Inc.|Mutant Actinosynnema pretiosum strain with increased maytansinoid production|
    JP2006510349A|2002-08-08|2006-03-30|スミスクライン・ビーチャム・コーポレイション|Method for isolation and purification of ansamitocin|
    US7432088B2|2003-05-08|2008-10-07|Immunogen Inc.|Methods for the production of ansamitocins|
    US20070135629A1|2005-12-08|2007-06-14|Millennium Pharmaceuticals, Inc.|Isolation of ansamitocins|
    US20110076232A1|2009-09-29|2011-03-31|Ludwig Institute For Cancer Research|Specific binding proteins and uses thereof|
    CN101921817A|2010-09-07|2010-12-22|上海交通大学|Method for enhancing fermentation yield of ansamycin|
    SG11201405628YA|2012-03-17|2014-10-30|Polyphor Ag|Conformationally constrained, fully synthetic macrocyclic compounds|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    JP52139385A|JPS6016236B2|1977-11-18|1977-11-18|
    [返回顶部]